9th National Symposium cum Workshop on “Recent Trends in Structural Bioinformatics and Computer Aided Drug Design”- SBCADD 2017
THEME
would like to take this wonderful privilege to invite you all to the 9thNational Symposium cum Workshop” going to be held during February 14th – 17th 2017, on the theme of “Recent Trends in Structural Bioinformatics and Computer Aided Drug Design” seeks to continue the good synergy obtained in the previous edition, providing a discussion forum from scientists, researchers, students and industrials about the latest ideas and realizations in the foundations, theory, models and applications for interdisciplinary and multidisciplinary research encompassing disciplines of Structural Biology, Molecular Biology, Structural Bioinformatics, Computer Aided Drug Design and Pharmacogenomics. In recent years, Computational Biology and Medical Informatics have seen significant advances driven by computational techniques making Bioinformatics and Computational Biology among the most vibrant research areas that could accelerate translational research comprising of the development and discovery of drugs against combating diseases that could enhance the livelihood and life expectancy of the individuals. The aim of SBCADD’2017 is to create a friendly environment that could lead to the establishment or strengthening of scientific collaborations and exchanges among attendees, and therefore, participation at SBCADD’2017 would provide an excellent opportunity to keep up with the cutting-edge research in such enlivening topics mentioned above and to network with other members of our community. We cordially invite you to submit abstract and participate in Symposium cum Workshop.

Syngene International is one of India’s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area. Based in Bangalore, Karnataka, the Company is situated in a 90 acre Special Economic Zone with over 100000 sq. mt of built up facilities. The state-of-the-art research facilities have been qualified by various pharmaceutical majors & regulatory agencies.
